South San Francisco, CA — November 3, 2025 — Biotech leader Genentech announced that it will present 46 abstracts, including 12 oral presentations, from its hematology portfolio at the upcoming ASH ...
A newly released market report on November 26, 2025 indicates that the global oncolytic virus CDMO services market is entering a phase of accelerated growth. According to the report, the market is pro...
Washington, Nov 24, 2025 — The U.S. Food and Drug Administration (FDA) has approved Itvisma, a gene therapy developed by Novartis, for a broader group of patients with spinal muscular atrophy (SMA), ...
November 2025 — As the cell and gene therapy (CGT) landscape continues to expand, the need for robust aseptic monitoring and contamination control is growing rapidly. According to a recent industry r...
Frankfurt, Germany · November 2025 — On November 6, 2025, the Cellex Symposium 2025 was successfully held in Frankfurt, Germany, bringing together over 100 leading scientists, industry executives, r...
The U.S. Food and Drug Administration (FDA) has added a boxed warning—its most serious level of safety alert—to Sarepta Therapeutics’ gene therapy Elevidys, following the deaths of two Duchenne mus...
November 2025 · Silver Spring, Maryland — The U.S. Food and Drug Administration (FDA) has announced a new “Plausible Mechanism” approval pathway to accelerate the review and authorization of ultra...
October 2025 · Cambridge, Massachusetts — Kelonia Therapeutics announced today a strategic collaboration with Johnson & Johnson to advance the development of in vivo CAR-T cell therapies, a next...
October 2025 · London, UK — A new study led by researchers at University College London (UCL) and Great Ormond Street Hospital has confirmed the long-term safety and efficacy of gene therapy for tre...
October 2025 · Worcester, Massachusetts — UMass Chan Medical School announced a five-year partnership with Makerere University and Mbarara University of Science and Technology in Uganda to strengthe...
October 2025 — Cambridge, MA — A team of scientists at the Massachusetts Institute of Technology (MIT) has developed a new system that allows researchers to precisely dial up or down the expression ...
October 2025 — Indianapolis, IN / Redwood City, CA — Eli Lilly and Company announced the acquisition of Adverum Biotechnologies in a deal valued at up to USD 262 million, strengthening Lilly’s stra...
86 198 5711 6962 
info@hillgene.com 
English
